PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.
UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...
Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback